Josiah M. Slotnick

PARTNER

Josiah M. Slotnick is a member of Cahill's corporate practice group.

Joe represents leading investment banking firms, commercial banks and public and private issuers, with a focus on leveraged finance transactions involving both syndicated institutional loans and asset based loans and new issuance of secured and unsecured high-yield debt securities. He represented the financing sources in a number of recent acquisitions, including the merger of Valeant Pharmaceuticals and Biovail Corporation, inVentiv Health by Thomas H. Lee Partners, Columbian Chemicals by Aditya Birla Group, the Gymboree Corporation by affiliates of Bain Capital Partners and several landmark leveraged buyouts of the LBO boom, including hospital-operator HCA, Travelport, Biomet and Lyondell Chemical Company. He also represents investment banks and financial advisors in connection with debt refinancings and comprehensive out-of-court debt restructurings, such as the recent $4.5 billion refinancing of DaVita and $5 billion exit financing for LyondellBasell's 2010 emergence from Chapter 11.

Joe works on both the bank and high-yield bond sides of acquisition financings and refinancings and has practiced in a variety of industries such as healthcare, life sciences, pharmaceuticals, financial services, technology, chemicals, telecom and gaming.